Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Effect of freeze-thaw on clarify performance of extracting solution with silkworm dropping].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2011

Same author

Estimation and projection of the HIV epidemic trend among the migrant population in China.

Biomedical and environmental sciences : BES·2011

Same author

Synthesis of novel cinnamanilides as potential immunosuppressive agents.

European journal of medicinal chemistry·2011

Same author

Characteristics of Raman spectra for graphene oxide from ab initio simulations.

The Journal of chemical physics·2011

Same author

Fe-catalysed oxidative C-H functionalization/C-S bond formation.

Chemical communications (Cambridge, England)·2011

Same author

Determination of grade and subtype of meningiomas by using histogram analysis of diffusion-tensor imaging metrics.

Radiology·2011

Search research articles

Related Experiment Video

Updated: May 12, 2026

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

Neuroprotection in glaucoma: present and future.

Shi-da Chen¹, Lu Wang, Xiu-lan Zhang

¹Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, Guangdong 510060, China.

Chinese Medical Journal

|April 19, 2013

Summary

This summary is machine-generated.

Glaucoma neuroprotection research explores various retinal ganglion cell death mechanisms. Future strategies may offer novel treatments beyond intraocular pressure reduction.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

Related Experiment Videos

Last Updated: May 12, 2026

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

Area of Science:

Ophthalmology
Neuroscience

Background:

Glaucoma is a leading cause of irreversible blindness.
Retinal ganglion cell (RGC) death is a hallmark of glaucoma pathogenesis.
Current treatments primarily focus on lowering intraocular pressure (IOP).

Purpose of the Study:

To review updated research on neuroprotection in glaucoma.
To summarize potential neuroprotective agents investigated for glaucoma.

Main Methods:

Systematic review of literature from PubMed and Google Scholar up to September 2012.
Keywords: glaucoma, neuroprotection, retinal ganglion cells.
Inclusion of relevant older articles and cited references.

Main Results:

Multiple mechanisms contribute to RGC death in glaucoma, including neurotrophic factor deprivation, excitotoxicity, oxidative stress, mitochondrial dysfunction, inflammation, apoptosis, ischemia, and protein misfolding.
Various neuroprotective strategies targeting these mechanisms have been investigated.
Promising future research areas include axonal transport failure, synaptic dysfunction, glial system involvement, and stem cell therapy.

Conclusions:

Neuroprotective strategies for glaucoma are continually evolving.
Further research into glaucoma pathogenesis is crucial for developing novel neuroprotection tactics.
Establishing standardized assessment systems for neuroprotection treatments is needed.